Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients

Sarah Johnson Sarah Johnson · · 1 min read · 0 views
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026

Sarah Johnson · Jun 15, 2026

Dr. Chae-Yong Kim of Seoul National University Bundang Hospital delivers oral presentation on interim data from 10 enrolled patients A manageable safety profile, with prolonged disease control and tumor recurrence inhibition observed in several patients

Rznomics Inc. logo

Rznomics Inc. logo

Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year]   Add AP News on Google Add AP News as your preferred source to see more of our stories on Google. Share Share freestar.queue.push(function() { let thisPlacement = "apnews_leaderboard"; window.fsAdCounts = window.fsAdCounts || {}; window.fsAdCounts[thisPlacement] = window.fsAdCounts[thisPlacement] + 1 || 0; let adList = document.getElementsByClassName(thisPlacement); if (adList.length

Read Full Article on Associated Press

How did this make you feel?

Comments (0)

Log in or create an account to leave a comment.

No comments yet. Be the first!